Biopharma SPAC Jiya Acquisition priced its $100M IPO. The company intends to start trading today on the Nasdaq under the symbol “JYAC”. The company in earlier filings has said it may raise up to $25 million more at the closing of any merger under terms of a forward purchase agreement. Notice of effectiveness.
Legacy said approximately 84 percent of the outstanding shares had been tendered and not withdrawn in the offer.
The new company would have an enterprise value of $788 million, the parties said.